'A Higher Ethical Obligation?' State Revenue Execs Speak Out in Crowell's Conversations
Client Alert | 1 min read | 01.15.14
Crowell & Moring's state tax team traveled from coast to coast in 2013 to introduce the corporate world to 10 of the country's top state tax decision makers. In Crowell's Conversations – a monthly column appearing in Bloomberg BNA's Weekly State Tax Report – we bring you timely and candid observations from different states' commissioners and their counsel. The revenue executives discussed everything from litigation and policy-making to resources and technology to their personal careers. While the questions and responses differed in each column, a common theme last year was the core belief that the states have a higher ethical obligation to get to the "right" answer rather than to collect the most revenue. We hope you have enjoyed getting to know our friends in the state revenue departments, and we look forward to bringing you more great interviews in 2014. Below are links to the first nine interviews.
- Michael Bryan, Director of the New Jersey Division of Taxation (December 6, 2013).
- Jozel Brunett, California Franchise Tax Board Chief Counsel (November 8, 2013).
- Julie Magee, Commissioner of the Alabama Department of Revenue (August 30, 2013).
- Tim Barfield, Secretary at the Louisiana Department of Revenue (July 19, 2013).
- Barbara Brohl, Executive Director and John Vecchiarelli, Senior Director of the Colorado Department of Revenue (June 21, 2013).
- Marshall Stranburg, Executive Director at the Florida Department of Revenue (May 3, 2013).
- Peter Franchot, Comptroller of Maryland (April 12, 2013).
- Milton Kimpson, General Counsel to the South Carolina Department of Revenue (March 15, 2013).
- Alan Levine, Chief Counsel With the District of Columbia's Office of Tax and Revenue (February 15, 2013).
Insights
Client Alert | 7 min read | 06.26.26
Federal Roundup: Updates for PBMs and Medicare Advantage Organizations
In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future.
Client Alert | 6 min read | 06.26.26
Client Alert | 4 min read | 06.25.26
Twin Executive Orders Seek to Spur Quantum Leap in Technology and Cybersecurity
Client Alert | 7 min read | 06.24.26
